Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)

China · Delayed Price · Currency is CNY

3.300

-0.160 (-4.62%)

Jul 30, 2026, 3:04 PM CST

SHE:002581 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Market Capitalization	2,177	4,948	7,020	9,632	10,391	14,085
Market Cap Growth	-54.98%	-29.51%	-27.12%	-7.30%	-26.23%	16.48%
Enterprise Value	2,181	4,817	6,706	9,536	10,515	14,117
Last Close Price	3.30	7.50	10.64	14.60	15.75	21.35

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
PE Ratio	-	-	-	-	-	51.98
PS Ratio	7.68	18.01	19.48	22.41	29.10	34.98
PB Ratio	1.14	2.54	3.47	4.43	4.19	5.70
P/TBV Ratio	1.27	2.83	3.84	4.91	4.60	6.25

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
EV/Sales Ratio	7.70	17.53	18.61	22.19	29.45	35.05

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Debt / Equity Ratio	0.03	0.03	0.00	0.01	0.07	0.07
Net Debt / Equity Ratio	-0.05	-0.08	-0.25	-0.06	-0.01	0.00
Net Debt / EBITDA Ratio	0.64	1.05	10.13	1.57	0.17	0.07
Net Debt / FCF Ratio	0.23	0.37	32.35	3.37	0.22	0.10
Asset Turnover	0.13	0.13	0.16	0.17	0.13	0.16
Inventory Turnover	1.80	1.77	1.06	1.13	1.06	1.27
Quick Ratio	2.74	2.68	7.89	3.02	1.05	1.83
Current Ratio	3.65	3.30	9.04	3.72	1.42	2.20
Return on Equity (ROE)	-8.72%	-8.11%	-6.81%	-13.84%	-0.03%	11.96%
Return on Assets (ROA)	-5.49%	-5.43%	-2.50%	-3.74%	-3.90%	-4.90%
Return on Invested Capital (ROIC)	-10.40%	-11.46%	-5.11%	-6.93%	0.48%	-9.00%
Return on Capital Employed (ROCE)	-9.60%	-9.60%	-4.30%	-7.10%	-7.00%	-8.20%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Earnings Yield	-6.14%	-2.35%	-1.96%	-3.45%	-0.14%	1.92%
FCF Yield	-19.06%	-8.76%	-0.22%	-0.42%	-0.83%	-0.76%
Payout Ratio	-	-	-	-	-	2.48%
Buyback Yield / Dilution	0.01%	0.04%	-0.01%	-0.22%	0.21%	0.00%
Total Shareholder Return	0.01%	0.04%	-0.01%	-0.22%	0.21%	0.00%